SynthesisFrontiers in medicine2022

The efficacy and safety of lebrikizumab monotherapy for the management of moderate-to-severe atopic dermatitis: A systematic review and meta-analysis.

Bader Bashrahil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.